GPM6B and central nervous system cancer: GPM6B promoted the transformation of glioma stem cells and inhibited growth of glioma by suppressing Integrin β1–mediated regulation of β-catenin, while reducing its own degradation through inhibition of the ubiquitinase SOCS3, thereby stabilizing its function in glioma.